| Full Name | Ashley Mccaw |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 3205 S Rural Rd, Tempe, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053662155 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ashley Mccaw, 3205 S Rural Rd, Tempe, AZ 85282-3853 Ph: () - | Ashley Mccaw, 3205 S Rural Rd, Tempe, AZ 85282-3853 Ph: (480) 730-7263 |
News Archive
Most people think that their planners or their iPhones keep them organized, when proteins such as liver kinase b1 (Lkb1) actually have a lot more to do with it. New research from postdoctoral fellow Lick Lai in the lab of USC scientist Andy McMahon published in Proceedings of the National Academy of Sciences (PNAS) sheds light on how this important protein keeps people organized on a basic level by promoting orderly skeletal growth and preventing skeletal tumors.
Loyola University Medical Center has launched the first clinical trial in the Midwest of an experimental melanoma treatment that genetically engineers a patient's immune system to fight the deadly cancer.
Ascenta Therapeutics announced today that encouraging results from a Phase I dose-escalation study of two combination therapy regimens containing AT-101, an oral, pan-Bcl-2 inhibitor, in patients with the most malignant type of brain tumor, were described in an oral presentation at the 2009 Joint Meeting of the Society for NeuroOncology (SNO) and AANS/CNS Section on Tumors in New Orleans, Louisiana (Concurrent Session VI: Radiation Oncology, October 23, 2009; Abstract # 449).
Acorda Therapeutics, Inc. today announced the U.S. Food and Drug Administration (FDA) Peripheral and Central Nervous System Drugs (PCNSD) Advisory Committee voted 12 to 1 that clinical data on Fampridine-SR 10 mg twice daily demonstrated substantial evidence of effectiveness as a treatment to improve walking in people with multiple sclerosis (MS) and voted 10 to 2 (1 abstention) that it is clinically meaningful and can be safe for use.
› Verified 5 days ago
Lauren Owens, MS Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1930 E Southern Ave, Tempe, AZ 85282 Phone: 480-456-0719 | |
Ms. Cheryl H. Davis, M.A. CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 8700 S Kyrene Rd, Tempe, AZ 85284 Phone: 480-783-4100 | |
Kristine Lyn Williams-gregory, M.S.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8700 S Kyrene Rd, Tempe, AZ 85284 Phone: 480-783-3167 Fax: 480-345-2052 | |
Ms. Debra Kay Mikkelsen, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 625 W Cornell Dr, Tempe, AZ 85283 Phone: 480-897-6233 Fax: 480-838-0061 | |
Ms. Lisa J. Monheit, M.S., CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 8700 S Kyrene Rd, Tempe, AZ 85284 Phone: 480-783-3220 | |
Mrs. Kelly Ingram, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Arizona State University Speech And Hearing, 975 S. Myrtle Lattie Coor Hall 2324, Tempe, AZ 85287 Phone: 480-965-5830 | |
Mrs. Diana Lynn Whitley-janowski, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1428 N Mcallister Ave, Tempe, AZ 85281 Phone: 602-620-8119 |